USPTO Affirms Abbott Protein Patent In War With Yeda

Law360, New York (May 27, 2010, 1:59 PM EDT) -- Abbott GmbH & Co. KG has cemented its victory in a 14-year-old dispute with Yeda Research & Development Co. Ltd. over a patent for a tumor necrosis factor protein, winning recognition that one of its patent applications is the earliest reference to the protein, which is used in autoimmune therapies.

The U.S. Patent and Trademark Office’s Board of Patent Appeals and Interferences on Wednesday awarded Abbott the benefit of its earliest-filed application and entered judgment against Yeda, which had long contended that it made reference to...
To view the full article, register now.